Obuli Ramachandran Nandhakumar

Vanakkam.

Dr Obuli Ramachandran N · Vitreoretinal Surgeon, Delhi NCR · MD (AIIMS) · MRCS (Ed) · FVRS · FAICO

I operate on retinas, and on the economics of the hospitals around them.

I am a vitreoretinal surgeon at Centre for Sight in New Delhi and Gurugram. I work on health economics in ophthalmology, and I advise hospitals, startups and investors as co-founder of Aavinyaa Strategies, a healthcare venture studio incubated at AIC NIFIE, IIM Mumbai.

Gurugram time

Trained and qualified atAIIMS New DelhiAravind Eye HospitalRoyal College of Surgeons of EdinburghIndian School of BusinessCorporate Finance Institute
5,000+

vitreoretinal surgeries performed

10,000+

intravitreal and laser procedures performed

30+

peer-reviewed publications across PubMed, EMBASE and Cochrane

100+

healthcare ventures evaluated through Aavinyaa Strategies

Sector report 2026-27

Five Years of Financials of India's Major Eye Care Chains and Hospitals

I studied the audited accounts of twelve eye care businesses from FY22 to FY26. The report has its own page with an interactive timeline and charts.

Open the sector report
About

About Me

I was born in Salem, Tamil Nadu. My family are weavers from Singalandapuram, a small village near Rasipuram, and both my parents come from small villages. My father was the second graduate in our family and worked as a bank manager. His job came with frequent transfers, so I grew up across the country and studied in more than seven schools.

I studied medicine at Kilpauk Medical College, Chennai. Ophthalmology was not my first choice. I chose it because I had the chance to train at the Dr Rajendra Prasad Centre for Ophthalmic Sciences at AIIMS New Delhi, the apex institute of our country. My love for the retina started there. My senior residents kept us back until midnight, made us examine the retina with the indirect ophthalmoscope and taught us the findings. Those nights left an imprint on me.

I joined Aravind Eye Hospital, Madurai, in 2017 for my vitreoretinal fellowship and stayed on as a consultant until 2021. I now work at Centre for Sight in Delhi NCR. I have performed more than 5,000 vitreoretinal surgeries and 10,000 intravitreal injections and laser procedures.

My interest in management started at Aravind. I attended the monthly reviews and quality control meetings, worked in LAICO outreach camps, and did capstone projects with visiting MBA students from the United States. My head of department, Dr Naresh Babu, has an MBA, and that made me want to study management.

I completed the Advanced Management Programme in Healthcare at the Indian School of Business and was on the Dean's List. I then completed the FMVA certification in financial modelling and valuation. I co-founded Aavinyaa Strategies, a healthcare venture studio incubated at AIC NIFIE, IIM Mumbai.

I divide my week between surgery and Aavinyaa. I write about healthcare economics for ophthalmologists because I want more doctors to understand financial statements.

Family

My wife, Dr Gauri Khare, is a vitreoretinal surgeon at Centre for Sight and a co-author on several of my papers. We live in Gurugram with our young daughter.

Outside Work

I collect automatic watches. I endure eternal pain year after year following , the Los Angeles Lakers and CSK. I read history and listen to a curated list of podcasts.

See some of the watches in my collection

Dr Obuli Ramachandran: With Gauri and our daughter at the Indian School of Business
With Gauri and our daughter at the Indian School of Business
Clinic and research

OCT and Cost-Effectiveness Analysis

I use two kinds of chart in my work. In clinic I read OCT scans of the macula. In research I use cost-effectiveness analysis to compare treatments.

250 µm
Plate I. The macula on optical coherence tomographyMove the cursor across the scan to measure retinal thickness. This is a drawing made in code and is not a patient scan.
Health economics

The Cost-Effectiveness Plane

Each point is one simulated comparison of a new treatment with the current standard. Points further right add more health. Points higher up cost more. The dashed line is the most a payer will spend for one year of good health. A treatment is cost-effective when most of the points fall below that line.

I am building this analysis for the treatments of diabetic macular oedema in India.

Open the sector report 2026-27

Plate II. The cost-effectiveness planeIllustration with simulated points.
Career

Work and Achievements

My training and work at AIIMS, Aravind Eye Hospital, Centre for Sight and Aavinyaa Strategies.

Chapter One

AIIMS

Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS New Delhi. MD Ophthalmology, 2013 to 2016.

  • Performed more than 100 phacoemulsification surgeries as a resident
  • Independently managed the trauma theatre and the eye casualty
  • Performed lid surgery, dacryocystorhinostomy, trabeculectomy and corneal transplants
  • Performed vitrectomies for endophthalmitis
  • Thesis on oral steroids in paediatric orbital cellulitis, with a comparison of treatment response in adults. We found meaningful improvement when steroids were started together with intravenous antibiotics
Dr Obuli Ramachandran: With my MD degree at the 45th AIIMS convocation, January 2018
With my MD degree at the 45th AIIMS convocation, January 2018
Chapter Two

Aravind

Aravind Eye Hospital, Madurai. Vitreoretinal Fellow, 2017 to 2019. Consultant, 2019 to 2021.

  • About 2,500 vitreoretinal surgeries in two and a half years, and more than 6,000 intravitreal injections and laser procedures
  • Vitreoretinal fellowship (FVRS) under Dr Naresh Babu
  • Surgery for retinal detachment, including cases with proliferative vitreoretinopathy, choroidal detachment and coloboma
  • Macular hole surgery, diabetic vitrectomy, scleral-fixated intraocular lenses, ocular trauma and 3-D heads-up surgery
  • As a consultant, headed my own operating day
  • Conducted masterclasses on scleral-fixated IOLs and diabetic vitrectomy
  • Presented at journal clubs and took classes for postgraduate residents
  • Co-author of two randomised trials: platelet-rich plasma against the inverted ILM flap for large macular holes, and intravitreal methotrexate in proliferative vitreoretinopathy
  • Worked with Google Research on AI screening for diabetic retinopathy
  • Outreach camps with LAICO, quality control meetings, and capstone projects with visiting MBA students from the United States
Dr Obuli Ramachandran: With Dr Naresh Babu
With Dr Naresh Babu
Dr Obuli Ramachandran: Surgical training in the operating theatre at Aravind
Surgical training in the operating theatre at Aravind
Dr Obuli Ramachandran: Outreach camp visit, Rameswaram
Outreach camp visit, Rameswaram
Chapter Three

Centre for Sight

Centre for Sight Eye Institute, Delhi NCR. Consultant Vitreoretinal Surgeon.

  • More than 2,500 vitreoretinal surgeries and 4,000 intravitreal injections and laser procedures
  • Eyeconic 2025 award for the highest number of vitreoretinal surgeries in the organisation in FY 2024 to 25
  • Helped build retina services in Agra, Hisar, Gurugram and Ranchi, and raised surgical capacity at Gurugram and Safdarjung Enclave
  • Surgical trainer for vitreoretinal fellows and Fellowship Co-Incharge
  • External examiner, invited by the National Board of Examinations, for the FNB Vitreoretina exit examination
  • Examiner for the FAICO examination of the All India Ophthalmological Society
  • Started and led process improvement and optimisation projects across the organisation
  • Led the organisation's evaluation of multiple AI products for ophthalmology
Dr Obuli Ramachandran: Centre for Sight
Centre for Sight
Dr Obuli Ramachandran: With senior colleagues at Centre for Sight
With senior colleagues at Centre for Sight
Dr Obuli Ramachandran: With the team at Centre for Sight
With the team at Centre for Sight
Chapter Four

Aavinyaa

Aavinyaa Strategies, a doctor-led healthcare venture studio. Co-founder and VP, Strategy and Operations.

  • Startups. I have evaluated more than 100 healthcare ventures. I advise founders on clinical validation, the CDSCO regulatory pathway, investor-ready financial models and market access through partner hospitals
  • Clinics, diagnostics and hospitals. I work with owners on throughput, ARPOB, occupancy, revenue cycle and denial reduction, and on site feasibility and expansion models for multi-location growth
  • Investors. I carry out clinical and operational due diligence for venture capital, private equity and angel investors, and I write sector and equity research on Indian healthcare
  • Incubators and CSR funders. I screen cohorts and mentor founders for incubators, and I help CSR funders design and verify healthcare projects
  • The All India Ophthalmological Society invited Aavinyaa Strategies to be its innovation partner
  • Aavinyaa operates as Moonshot Advisory Private Limited and is incubated at AIC NIFIE, IIM Mumbai
  • Advanced Management Programme in Healthcare, Indian School of Business, Dean's List
  • Financial Modelling and Valuation Analyst, Corporate Finance Institute
Dr Obuli Ramachandran: Aavinyaa Strategies, innovation partner of the All India Ophthalmological Society, at AIOC 2026, Jaipur
Aavinyaa Strategies, innovation partner of the All India Ophthalmological Society. AIOC 2026, Jaipur
Dr Obuli Ramachandran: ISB graduation, 2025
ISB graduation, 2025
Expertise

Areas of Expertise

My work covers three areas: retina surgery, health economics in ophthalmology, and healthcare consulting.

Retina and Vitreoretinal Surgery

I am a vitreoretinal surgeon in Delhi NCR. I operate at Centre for Sight hospitals in New Delhi and Gurugram and treat medical and surgical diseases of the retina.

Conditions I treat

Retinal detachmentDiabetic retinopathyDiabetic macular oedemaMacular holeEpiretinal membraneVitreous haemorrhageAge-related macular degenerationRetinal vein occlusionCentral serous chorioretinopathyProliferative vitreoretinopathyEndophthalmitisEye injuries involving the retina

Procedures I perform

Pars plana vitrectomyRetinal detachment surgeryScleral bucklingMacular hole surgery with ILM peelingDiabetic vitrectomyAnti-VEGF injectionsOzurdex implantRetinal laserScleral-fixated and glued IOL

Health Economics in Ophthalmology

I study what eye treatments cost in India and what patients gain from them. I use cost-utility analysis, real-world evidence and systematic reviews.

Research subjects

Cost-effectiveness of anti-VEGF therapyAflibercept, ranibizumab and biosimilarsTreatment burden in diabetic macular oedemaValue-based care in eye hospitalsAI screening for diabetic retinopathyValidation of indigenous medical devices

Methods

Cost-utility analysisHealth economics and outcomes researchReal-world evidenceSystematic review and meta-analysisRandomised controlled trials

Healthcare Consulting and Strategy

Through Aavinyaa Strategies I advise eye hospitals, healthcare startups and investors in India. I combine surgical practice with training in management and finance.

Work for hospitals and clinics

Eye hospital operationsRetina service set-upHub and spoke network designRevenue cycle and denial reductionSite feasibility and expansionFinancial literacy for doctors

Work for startups and investors

Clinical validationCDSCO regulatory pathwayClinical and operational due diligenceSector and equity researchIndian eye care market analysisFinancial modelling and valuation
Clinic

A Fundus, Annotated

Six findings I look for when I examine the retina. Choose a number to read about each one.

1 of 6

What it is
Usual cause
What I do

This is a teaching drawing that combines findings from different diseases.

Academic

Papers, Presentations and Awards

Most Cited Papers

21Citations

Comparison of platelet-rich plasma and inverted internal limiting membrane flap for the management of large macular holes: a pilot study

Babu N, Kohli P, Ramachandran NO, Adenuga OO, Ahuja A, Ramasamy K. Indian J Ophthalmol. 2020;68(5):880-884. doi:10.4103/ijo.IJO_1357_19

8Citations

Comparison of surgical performance of internal limiting membrane peeling using a 3-D visualization system with conventional microscope

Babu N, Kohli P, Ramachandran NO, Ramasamy K. Ophthalmic Surg Lasers Imaging Retina. 2018;49(12):941-945.

6Citations

Intravitreal methotrexate as an adjuvant in vitrectomy in cases of retinal detachment with proliferative vitreoretinopathy

Rajan RP, Babu KN, Arumugam KK, Muraleedharan S, Ramachandran O, et al. Graefes Arch Clin Exp Ophthalmol. 2025;263(2):387-391. doi:10.1007/s00417-024-06665-w

6Citations

Rare cause of floaters: a motile live worm in vitreous cavity

Rajan RP, Jena S, Ramachandran NO, Kohli P. Indian J Ophthalmol. 2019;67(9):1490-1492. doi:10.4103/ijo.IJO_79_19

5Citations

Abnormal retinal vasculature in a young child: a diagnostic dilemma

Kannan NB, Kohli P, Ramachandran NO. Ocul Immunol Inflamm. 2021;29(1):175-178.

Citation counts from Crossref, October 2026. Full list on ORCID 0000-0001-8498-9538 and Google Scholar.

Published in 2026

2026
Real-world efficacy of higher-dose aflibercept in pro-re-nata dosing without loading phasesFirst author. Indian J Ophthalmol. 74(11):1714-1719. 194 eyes, 22.6% fewer annual visits. DOI
2026
Long-term analysis of intravitreal brolucizumab in chronic central serous retinopathy with neovascularizationIndian J Ophthalmol. 74(6):893-900. DOI
2026
Peep into anti-vascular endothelial growth factorReview. Indian J Ophthalmol. 74(5):635-638. DOI
Now
Work in progressCost-utility analysis of treatments for diabetic macular oedema in India. PROSPERO-registered systematic review of endophthalmitis after cataract surgery.

Examiner and Reviewer Roles

Review
Peer ReviewerReviewer for national and international journals. I have reviewed more than 30 papers for publication.
NBE
External Examiner, FNB VitreoretinaInvited by the National Board of Examinations for the fellowship exit examination.
AIOS
Examiner, FAICOExaminer for the Fellowship of the All India Collegium of Ophthalmology.
Training
Surgical TrainerTrainer for vitreoretinal fellows and Fellowship Co-Incharge at Centre for Sight.
Dr Obuli Ramachandran: Examining at the FAICO examination
Examining at the FAICO examination

Presentations

2026
ASRS Annual MeetingExpert panel presentation at the American Society of Retina Specialists: "Platform Matters? Comparative Effectiveness of 5 Vitrectomy Systems in 1,082 Primary Vitreoretinal Surgeries".
2026
ARVO Annual MeetingPoster on the pooled prevalence of dry eye disease, 31.8%. Abstract 446317.
2026
Saudi Retina Symposium, JeddahInvited presentation.
2025
MEOM, DubaiInvited speaker.
2021 to 2026
All India Ophthalmological Society Annual ConferenceInvited speaker in 2021, 2022, 2024, 2025 and 2026. In 2026 I spoke on the glued IOL in the instruction course on scleral-fixated lenses.
2022 to 2025
EURETINASurgical videos invited in 2022, 2023 and 2025.
2023
APVRS, Hong KongSurgical video presentation. Won Asia's Best Surgical Video.
Ongoing
Invited Industry TalksSpeaker for Novartis, AbbVie, Sun Pharma and Reliance Life Sciences on my experience with anti-VEGF therapy and Ozurdex.
2026
Panel on AI in HealthcarePanelist representing Centre for Sight.
2026
Aravind Golden Jubilee Reunion Meet, MaduraiAlumni talk, December.

Awards and Recognition

2023

Asia's Best Surgical Video, APVRS

Awarded at the Asia-Pacific Vitreo-retina Society congress in Hong Kong.

2025 and 2026

Best Video Award, SFO Session, AIOS

Won in two consecutive years at the annual conference of the All India Ophthalmological Society.

Dr Obuli Ramachandran: With the trophy at the AIOS annual conference
With the trophy at the AIOS annual conference
Multiple years

Best Video Award, Ophthalmic Premier League

Won more than once at the Ophthalmic Premier League of the All India Ophthalmological Society.

Dr Obuli Ramachandran: Eyeconic 2025 certificate
Eyeconic 2025 certificate
2025

Eyeconic Award, Centre for Sight

For the highest number of vitreoretinal surgeries in the organisation in FY 2024 to 25, and for building retina services across several centres.

Dr Obuli Ramachandran: ISB graduation, 2025
ISB graduation, 2025
ISB

Dean's List, Indian School of Business

Advanced Management Programme in Healthcare. Awarded to the top five of the cohort.

2020

Best Poster in Vitreo Retina, TNOA

Tamil Nadu Ophthalmic Association annual conference.

Degrees and Fellowships

6/60MD
6/36MRCS (Ed)
6/24FVRS · FAICO
6/12AMPH · FMVA
6/9AIIMS · Aravind · Royal College of Surgeons of Edinburgh · ISB · CFI
6/6If you can read this line, your macula is doing its job.
Questions

Frequently Asked Questions

Who is Dr Obuli Ramachandran?

I am Dr Obuli Ramachandran Nandhakumar, a consultant vitreoretinal surgeon at Centre for Sight in Delhi NCR. I trained at AIIMS New Delhi and Aravind Eye Hospital, Madurai. I have performed more than 5,000 vitreoretinal surgeries and 10,000 intravitreal injections and laser procedures. I am also the co-founder of Aavinyaa Strategies, a healthcare venture studio.

Where does Dr Obuli Ramachandran see retina patients, and how do I book an appointment?

I see retina patients at Centre for Sight hospitals in Delhi NCR, including New Delhi and Gurugram. To book an appointment, call Centre for Sight on 011-42504250.

Which retinal conditions does he treat?

I treat retinal detachment, diabetic retinopathy, diabetic macular oedema, macular hole, epiretinal membrane, vitreous haemorrhage, age-related macular degeneration, retinal vein occlusion, central serous chorioretinopathy, endophthalmitis and eye injuries that involve the retina.

What is a vitrectomy, and when is it needed?

A vitrectomy is an operation in which I remove the vitreous gel from inside the eye through three small openings. It is done for retinal detachment, macular hole, bleeding inside the eye from diabetes, and infection inside the eye.

How urgent is a retinal detachment?

A retinal detachment is an emergency. New flashes of light, a sudden shower of floaters or a dark curtain across part of your vision need a retina examination on the same day. Surgery works best before the centre of the retina detaches.

What are intravitreal injections used for?

I inject anti-VEGF medicines or a steroid implant into the eye to treat diabetic macular oedema, wet age-related macular degeneration and retinal vein occlusion. The procedure takes a few minutes under anaesthetic drops.

How often should a person with diabetes have a retina examination?

A person with diabetes needs a retina examination once a year while the retina is normal, and more often once diabetic retinopathy is found.

What health economics research does he do in ophthalmology?

I study what eye treatments cost and what patients gain from them. My published work includes a study of higher-dose aflibercept that reduced clinic visits by 22.6%. I am building a cost-utility analysis of treatments for diabetic macular oedema in India.

Does he advise eye hospitals, healthcare startups and investors?

Yes. Through Aavinyaa Strategies I advise healthcare startups on clinical validation and regulatory approval, work with clinic and hospital owners on operations and expansion, and carry out clinical and operational due diligence for venture capital, private equity and angel investors. I have evaluated more than 100 healthcare ventures.

What is the Sector Report 2026-27?

It is my study of five years of audited financial statements of twelve Indian eye care chains and hospitals, from FY22 to FY26. It covers market size, government scheme rates, return on capital, valuation multiples and predictions to 2030.

How do I invite Dr Obuli Ramachandran to speak or collaborate?

Write to me at the address in the Contact section. I speak on vitreoretinal surgery, anti-VEGF therapy, health economics in ophthalmology and AI in eye care.

Contact

Enquiries and Appointments

Professional enquiries

Advisory roles, health economics and outcomes research, clinical validation, speaking and collaborations.

dr.obuliramachandran@gmail.com

Profiles

ORCID 0000-0001-8498-9538

Publications on Google Scholar

LinkedIn

For patients

I see retina patients at Centre for Sight in Delhi NCR. To book an appointment, call Centre for Sight.

011-42504250